All sites C00-96,D32-33,D42-43,D45-47,D76 226 88.2 4.1 3.7 1.0 3.0
Mouth, pharynx C00-14 4 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 - - - - - -
Digestive organs C15-26 37 78.6 5.9 9.1 1.1 5.3
  Oesophagus C15 1 100.0 - - - -
  Stomach C16 5 100.0 - - - -
  Small intestine C17 0 100.0 - - - -
  Colon C18 11 91.2 - 3.5 - 5.3
  Rectum, rectosigmoid C19-20 4 100.0 - - - -
  Anus C21 0 100.0 - - - -
  Liver C22 2 60.0 - 30.0 - 10.0
  Gallbladder, bile ducts C23-24 2 50.0 16.7 25.0 - 8.3
  Pancreas C25 10 55.1 18.4 16.3 2.0 8.2
  Other digestive organs C26 1 50.0 - 16.7 16.7 16.7
Respiratory organs C30-39 11 62.3 18.9 11.3 - 7.5
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 10 63.5 19.2 11.5 - 5.8
  Mediastinum, pleura C38 0 - - - - 100.0
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 8 97.4 2.6 - - -
Skin, non-melanoma C44 13 100.0 - - - -
Mesothelioma C45 - - - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 92.3 7.7 - - -
Breast C50 68 99.1 0.6 - 0.3 -
Female genital organs C51-58 23 93.1 1.7 2.6 1.7 0.9
  Cervix uteri C53 2 100.0 - - - -
  Corpus uteri C54 11 100.0 - - - -
  Uterus, other C55,C58 0 - - 50.0 50.0 -
  Ovary C56 6 84.4 6.3 3.1 3.1 3.1
  Other female genital C51-52,C57 4 94.4 - 5.6 - -
Urinary organs C64-68 12 93.1 - 5.2 1.7 -
  Kidney C64 7 94.3 - 2.9 2.9 -
  Bladder and urinary tract2 C65-68 5 91.3 - 8.7 - -
Eye C69 0 - 100.0 - - -
Brain, central nervous system C70-72,D32-33,D42-43 9 77.8 - 13.3 - 8.9
Thyroid gland C73 8 97.6 2.4 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 9 57.8 15.6 11.1 2.2 13.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 21 76.2 9.5 1.9 3.8 8.6
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 8 100.0 - - - -
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 4 71.4 9.5 4.8 4.8 9.5
  Leukaemia C91-95 4 84.2 10.5 5.3 - -
  Myelodysplastic syndromes D46 2 37.5 25.0 - - 37.5
  Myeloproliferaitive neoplasms D45,D47 2 8.3 33.3 - 25.0 33.3
Not included above
  Carcinoma in situ of the breast D05 4 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 5 100.0 - - - -
  Borderline tumour of the ovary D39 2 100.0 - - - -
  Basal cell carcinoma of the skin 65 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.